» Articles » PMID: 37383236

Infection with Hypervirulent Triggers Emergency Myelopoiesis but Not Trained Immunity

Overview
Journal Front Immunol
Date 2023 Jun 29
PMID 37383236
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: During infection, bone marrow (BM) hematopoiesis is reprogrammed toward myeloid cell production, a mechanism named emergency myelopoiesis. In addition to replenishing myeloid cells, emergency myelopoiesis has been linked to trained immunity, a process that allows enhanced innate immune responses to secondary challenges. Although hematopoietic alterations during tuberculosis (TB) have been described and may colonize the BM, studies using the mouse model of infection and the laboratory reference strain H37Rv have demonstrated limited emergency myelopoiesis and trained immunity.

Methods: To further address this issue, we aerosol- infected C57BL/6 mice with high doses of the hypervirulent M. tuberculosis isolate HN878 and monitored alterations to the BM. This experimental model better resembles the human blood immune signature of TB.

Results And Discussion: We found increased frequencies of lineageSca-1cKit (LSK) cells and the granulocyte/macrophage progenitor (GMP) population. At the mature cell level, we observed an increase of monocytes and neutrophils in the blood and lung, likely reflecting the increased BM myeloid output. Monocytes or monocyte-derived macrophages recovered from the BM of HN878-infected mice did not show signs of trained immunity, suggesting an uncoupling of emergency myelopoiesis and trained immunity in the BM. Surprisingly, HN878-induced emergency myelopoiesis was not fully dependent on IFNγ, as mice lacking this cytokine and infected under the same conditions as wild-type mice still presented BM alterations. These data expand our understanding of the immune response to and raise awareness of pathogen strain-imposed differences to host responses.

Citing Articles

Trained immunity in chronic inflammatory diseases and cancer.

Hajishengallis G, Netea M, Chavakis T Nat Rev Immunol. 2025; .

PMID: 39891000 DOI: 10.1038/s41577-025-01132-x.


The chosen few: isolates for IMPAc-TB.

Larsen S, Abdelaal H, Plumlee C, Cohen S, Kim H, Barrett H Front Immunol. 2024; 15:1427510.

PMID: 39530100 PMC: 11551615. DOI: 10.3389/fimmu.2024.1427510.

References
1.
de Bruin A, Libregts S, Valkhof M, Boon L, Touw I, Nolte M . IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood. 2011; 119(6):1543-54. DOI: 10.1182/blood-2011-07-367706. View

2.
Berry M, Graham C, McNab F, Xu Z, Bloch S, Oni T . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466(7309):973-7. PMC: 3492754. DOI: 10.1038/nature09247. View

3.
Matatall K, Jeong M, Chen S, Sun D, Chen F, Mo Q . Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation. Cell Rep. 2016; 17(10):2584-2595. PMC: 5161248. DOI: 10.1016/j.celrep.2016.11.031. View

4.
Schultze J, Mass E, Schlitzer A . Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation. Immunity. 2019; 50(2):288-301. DOI: 10.1016/j.immuni.2019.01.019. View

5.
Moreira-Teixeira L, Stimpson P, Stavropoulos E, Hadebe S, Chakravarty P, Ioannou M . Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat Commun. 2020; 11(1):5566. PMC: 7643080. DOI: 10.1038/s41467-020-19412-6. View